StageZero Life Sciences Ltd.
SZLSF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,415 | -$7,484 | -$6,864 | -$3,482 |
| Dep. & Amort. | $437 | $509 | $216 | $298 |
| Deferred Tax | $0 | -$1,644 | $2,818 | -$2,406 |
| Stock-Based Comp. | $239 | $391 | $637 | $741 |
| Change in WC | $3,709 | -$460 | -$80 | -$377 |
| Other Non-Cash | $3,502 | -$267 | $209 | $634 |
| Operating Cash Flow | -$3,529 | -$8,955 | -$3,064 | -$4,591 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$148 | -$72 | -$44 |
| Net Acquisitions | $0 | $81 | $0 | $11 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $46 | $0 | -$0 |
| Investing Cash Flow | $0 | -$21 | -$72 | -$33 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $290 | -$388 | $519 | $649 |
| Stock Issued | $1,543 | $3,107 | $9,551 | $3,941 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $61 | $1,385 | -$407 | $0 |
| Financing Cash Flow | $1,833 | $4,103 | $9,663 | $4,589 |
| Forex Effect | -$13 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,709 | -$4,872 | $6,526 | -$35 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,725 | $6,597 | $71 | $106 |
| End Cash | $16 | $1,725 | $6,597 | $71 |
| Free Cash Flow | -$3,529 | -$9,103 | -$3,137 | -$4,635 |